Defining childhood severe falciparum malaria for intervention studies.

<h4>Background</h4>Clinical trials of interventions designed to prevent severe falciparum malaria in children require a clear endpoint. The internationally accepted definition of severe malaria is sensitive, and appropriate for clinical purposes. However, this definition includes individ...

Full description

Bibliographic Details
Main Authors: Philip Bejon, James A Berkley, Tabitha Mwangi, Edna Ogada, Isaiah Mwangi, Kathryn Maitland, Thomas Williams, J Anthony G Scott, Mike English, Brett S Lowe, Norbert Peshu, Charles R J C Newton, Kevin Marsh
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2007-08-01
Series:PLoS Medicine
Online Access:https://doi.org/10.1371/journal.pmed.0040251
_version_ 1819042381941440512
author Philip Bejon
James A Berkley
Tabitha Mwangi
Edna Ogada
Isaiah Mwangi
Kathryn Maitland
Thomas Williams
J Anthony G Scott
Mike English
Brett S Lowe
Norbert Peshu
Charles R J C Newton
Kevin Marsh
author_facet Philip Bejon
James A Berkley
Tabitha Mwangi
Edna Ogada
Isaiah Mwangi
Kathryn Maitland
Thomas Williams
J Anthony G Scott
Mike English
Brett S Lowe
Norbert Peshu
Charles R J C Newton
Kevin Marsh
author_sort Philip Bejon
collection DOAJ
description <h4>Background</h4>Clinical trials of interventions designed to prevent severe falciparum malaria in children require a clear endpoint. The internationally accepted definition of severe malaria is sensitive, and appropriate for clinical purposes. However, this definition includes individuals with severe nonmalarial disease and coincident parasitaemia, so may lack specificity in vaccine trials. Although there is no "gold standard" individual test for severe malaria, malaria-attributable fractions (MAFs) can be estimated among groups of children using a logistic model, which we use to test the suitability of various case definitions as trial endpoints.<h4>Methods and findings</h4>A total of 4,583 blood samples were taken from well children in cross-sectional surveys and from 1,361 children admitted to a Kenyan District hospital with severe disease. Among children under 2 y old with severe disease and over 2,500 parasites per microliter of blood, the MAFs were above 85% in moderate- and low-transmission areas, but only 61% in a high-transmission area. HIV and malnutrition were not associated with reduced MAFs, but gastroenteritis with severe dehydration (defined by reduced skin turgor), lower respiratory tract infection (clinician's final diagnosis), meningitis (on cerebrospinal fluid [CSF] examination), and bacteraemia were associated with reduced MAFs. The overall MAF was 85% (95% confidence interval [CI] 83.8%-86.1%) without excluding these conditions, 89% (95% CI 88.4%-90.2%) after exclusions, and 95% (95% CI 94.0%-95.5%) when a threshold of 2,500 parasites/mul was also applied. Applying a threshold and exclusion criteria reduced sensitivity to 80% (95% CI 77%-83%).<h4>Conclusions</h4>The specificity of a case definition for severe malaria is improved by applying a parasite density threshold and by excluding children with meningitis, lower respiratory tract infection (clinician's diagnosis), bacteraemia, and gastroenteritis with severe dehydration, but not by excluding children with HIV or malnutrition.
first_indexed 2024-12-21T09:40:00Z
format Article
id doaj.art-0c33db851884460ab0111771e7f6a105
institution Directory Open Access Journal
issn 1549-1277
1549-1676
language English
last_indexed 2024-12-21T09:40:00Z
publishDate 2007-08-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Medicine
spelling doaj.art-0c33db851884460ab0111771e7f6a1052022-12-21T19:08:29ZengPublic Library of Science (PLoS)PLoS Medicine1549-12771549-16762007-08-0148e25110.1371/journal.pmed.0040251Defining childhood severe falciparum malaria for intervention studies.Philip BejonJames A BerkleyTabitha MwangiEdna OgadaIsaiah MwangiKathryn MaitlandThomas WilliamsJ Anthony G ScottMike EnglishBrett S LoweNorbert PeshuCharles R J C NewtonKevin Marsh<h4>Background</h4>Clinical trials of interventions designed to prevent severe falciparum malaria in children require a clear endpoint. The internationally accepted definition of severe malaria is sensitive, and appropriate for clinical purposes. However, this definition includes individuals with severe nonmalarial disease and coincident parasitaemia, so may lack specificity in vaccine trials. Although there is no "gold standard" individual test for severe malaria, malaria-attributable fractions (MAFs) can be estimated among groups of children using a logistic model, which we use to test the suitability of various case definitions as trial endpoints.<h4>Methods and findings</h4>A total of 4,583 blood samples were taken from well children in cross-sectional surveys and from 1,361 children admitted to a Kenyan District hospital with severe disease. Among children under 2 y old with severe disease and over 2,500 parasites per microliter of blood, the MAFs were above 85% in moderate- and low-transmission areas, but only 61% in a high-transmission area. HIV and malnutrition were not associated with reduced MAFs, but gastroenteritis with severe dehydration (defined by reduced skin turgor), lower respiratory tract infection (clinician's final diagnosis), meningitis (on cerebrospinal fluid [CSF] examination), and bacteraemia were associated with reduced MAFs. The overall MAF was 85% (95% confidence interval [CI] 83.8%-86.1%) without excluding these conditions, 89% (95% CI 88.4%-90.2%) after exclusions, and 95% (95% CI 94.0%-95.5%) when a threshold of 2,500 parasites/mul was also applied. Applying a threshold and exclusion criteria reduced sensitivity to 80% (95% CI 77%-83%).<h4>Conclusions</h4>The specificity of a case definition for severe malaria is improved by applying a parasite density threshold and by excluding children with meningitis, lower respiratory tract infection (clinician's diagnosis), bacteraemia, and gastroenteritis with severe dehydration, but not by excluding children with HIV or malnutrition.https://doi.org/10.1371/journal.pmed.0040251
spellingShingle Philip Bejon
James A Berkley
Tabitha Mwangi
Edna Ogada
Isaiah Mwangi
Kathryn Maitland
Thomas Williams
J Anthony G Scott
Mike English
Brett S Lowe
Norbert Peshu
Charles R J C Newton
Kevin Marsh
Defining childhood severe falciparum malaria for intervention studies.
PLoS Medicine
title Defining childhood severe falciparum malaria for intervention studies.
title_full Defining childhood severe falciparum malaria for intervention studies.
title_fullStr Defining childhood severe falciparum malaria for intervention studies.
title_full_unstemmed Defining childhood severe falciparum malaria for intervention studies.
title_short Defining childhood severe falciparum malaria for intervention studies.
title_sort defining childhood severe falciparum malaria for intervention studies
url https://doi.org/10.1371/journal.pmed.0040251
work_keys_str_mv AT philipbejon definingchildhoodseverefalciparummalariaforinterventionstudies
AT jamesaberkley definingchildhoodseverefalciparummalariaforinterventionstudies
AT tabithamwangi definingchildhoodseverefalciparummalariaforinterventionstudies
AT ednaogada definingchildhoodseverefalciparummalariaforinterventionstudies
AT isaiahmwangi definingchildhoodseverefalciparummalariaforinterventionstudies
AT kathrynmaitland definingchildhoodseverefalciparummalariaforinterventionstudies
AT thomaswilliams definingchildhoodseverefalciparummalariaforinterventionstudies
AT janthonygscott definingchildhoodseverefalciparummalariaforinterventionstudies
AT mikeenglish definingchildhoodseverefalciparummalariaforinterventionstudies
AT brettslowe definingchildhoodseverefalciparummalariaforinterventionstudies
AT norbertpeshu definingchildhoodseverefalciparummalariaforinterventionstudies
AT charlesrjcnewton definingchildhoodseverefalciparummalariaforinterventionstudies
AT kevinmarsh definingchildhoodseverefalciparummalariaforinterventionstudies